Infectious Vaccines Market Report

Global and Region Infectious Vaccines Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：179
  • REPORT CODE：GMM1003915
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.

    Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.

    The report details the trend, potential and market size of Infectious Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Infectious Vaccinesmarket, defines the market attractiveness level of Infectious Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Infectious Vaccines industry, describes the types of Infectious Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Infectious Vaccines market and the development prospects and opportunities of Infectious Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Infectious Vaccines market in Chapter 13.

    By Player:

    • Novartis AG (Switzerland)

    • Emergent Bio Solutions Inc (US)

    • Sanofi Pasteur (France)

    • Merck and Company (US)

    • Johnson and Johnson (US)

    • CSL Limited (Australia)

    • Bavarian Nordic (Denmark)

    • Pfizer Inc (US)

    • GlaxoSmithKline plc (UK)

    • MedImmune LLC (US)

    By Type:

    • Preventive vaccine

    • Therapeutic vaccine

    By End-User:

    • Adults

    • Pediatrics

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Infectious Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Infectious Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Infectious Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Infectious Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Infectious Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global Infectious Vaccines Consumption (2017-2022)

    • 7.2 United States Infectious Vaccines Consumption (2017-2022)

    • 7.3 Europe Infectious Vaccines Consumption (2017-2022)

    • 7.4 China Infectious Vaccines Consumption (2017-2022)

    • 7.5 Japan Infectious Vaccines Consumption (2017-2022)

    • 7.6 India Infectious Vaccines Consumption (2017-2022)

    • 7.7 South Korea Infectious Vaccines Consumption (2017-2022)

    8 Region and Country-wise Infectious Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global Infectious Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States Infectious Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe Infectious Vaccines Consumption Forecast (2022-2028)

    • 8.4 China Infectious Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan Infectious Vaccines Consumption Forecast (2022-2028)

    • 8.6 India Infectious Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea Infectious Vaccines Consumption Forecast (2022-2028)

    9 Global Infectious Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Infectious Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Preventive vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Therapeutic vaccine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Infectious Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adults Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pediatrics Consumption and Growth Rate (2017-2022)

    10 Global Infectious Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global Infectious Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Preventive vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Therapeutic vaccine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Infectious Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

    11 Global Infectious Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Infectious Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Infectious Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Infectious Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Infectious Vaccines Market Competitive Analysis

    • 14.1 Novartis AG (Switzerland)

      • 14.1.1 Novartis AG (Switzerland) Company Details

      • 14.1.2 Novartis AG (Switzerland) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis AG (Switzerland) Infectious Vaccines Product and Service

    • 14.2 Emergent Bio Solutions Inc (US)

      • 14.2.1 Emergent Bio Solutions Inc (US) Company Details

      • 14.2.2 Emergent Bio Solutions Inc (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Emergent Bio Solutions Inc (US) Infectious Vaccines Product and Service

    • 14.3 Sanofi Pasteur (France)

      • 14.3.1 Sanofi Pasteur (France) Company Details

      • 14.3.2 Sanofi Pasteur (France) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi Pasteur (France) Infectious Vaccines Product and Service

    • 14.4 Merck and Company (US)

      • 14.4.1 Merck and Company (US) Company Details

      • 14.4.2 Merck and Company (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck and Company (US) Infectious Vaccines Product and Service

    • 14.5 Johnson and Johnson (US)

      • 14.5.1 Johnson and Johnson (US) Company Details

      • 14.5.2 Johnson and Johnson (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Johnson and Johnson (US) Infectious Vaccines Product and Service

    • 14.6 CSL Limited (Australia)

      • 14.6.1 CSL Limited (Australia) Company Details

      • 14.6.2 CSL Limited (Australia) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 CSL Limited (Australia) Infectious Vaccines Product and Service

    • 14.7 Bavarian Nordic (Denmark)

      • 14.7.1 Bavarian Nordic (Denmark) Company Details

      • 14.7.2 Bavarian Nordic (Denmark) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bavarian Nordic (Denmark) Infectious Vaccines Product and Service

    • 14.8 Pfizer Inc (US)

      • 14.8.1 Pfizer Inc (US) Company Details

      • 14.8.2 Pfizer Inc (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Inc (US) Infectious Vaccines Product and Service

    • 14.9 GlaxoSmithKline plc (UK)

      • 14.9.1 GlaxoSmithKline plc (UK) Company Details

      • 14.9.2 GlaxoSmithKline plc (UK) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GlaxoSmithKline plc (UK) Infectious Vaccines Product and Service

    • 14.10 MedImmune LLC (US)

      • 14.10.1 MedImmune LLC (US) Company Details

      • 14.10.2 MedImmune LLC (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 MedImmune LLC (US) Infectious Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Infectious Vaccines

    • Figure Infectious Vaccines Picture

    • Table Global Infectious Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Infectious Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Infectious Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Infectious Vaccines Consumption by Country (2017-2022)

    • Figure United States Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Infectious Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Infectious Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Infectious Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Preventive vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatrics Consumption and Growth Rate (2017-2022)

    • Figure Global Preventive vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Infectious Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Infectious Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis AG (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table Novartis AG (Switzerland) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG (Switzerland) Infectious Vaccines Product and Service

    • Table Emergent Bio Solutions Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Emergent Bio Solutions Inc (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent Bio Solutions Inc (US) Infectious Vaccines Product and Service

    • Table Sanofi Pasteur (France) (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur (France) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur (France) Infectious Vaccines Product and Service

    • Table Merck and Company (US) (Foundation Year, Company Profile and etc.)

    • Table Merck and Company (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck and Company (US) Infectious Vaccines Product and Service

    • Table Johnson and Johnson (US) (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson (US) Infectious Vaccines Product and Service

    • Table CSL Limited (Australia) (Foundation Year, Company Profile and etc.)

    • Table CSL Limited (Australia) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Limited (Australia) Infectious Vaccines Product and Service

    • Table Bavarian Nordic (Denmark) (Foundation Year, Company Profile and etc.)

    • Table Bavarian Nordic (Denmark) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic (Denmark) Infectious Vaccines Product and Service

    • Table Pfizer Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc (US) Infectious Vaccines Product and Service

    • Table GlaxoSmithKline plc (UK) (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc (UK) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc (UK) Infectious Vaccines Product and Service

    • Table MedImmune LLC (US) (Foundation Year, Company Profile and etc.)

    • Table MedImmune LLC (US) Infectious Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table MedImmune LLC (US) Infectious Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US